We observed that high ATP1F1 was associated with increased OS in ERα+ breast cancer patients (Supplementary Fig. 10B) while higher ATP5G1 correlated with reduced RFS in ERα+ breast cancer patients (Supplementary Fig. 10C). Here, ATP5MC1 is linked to breast cancer.